Cargando…

A Novel c-Mesenchymal-Epithelial Transition Factor Intergenic Fusion Response to Crizotinib in a Chinese Patient With Lung Adenocarcinoma: A Case Report

BACKGROUND: The c-mesenchymal–epithelial transition factor (C-MET) is an oncogene encoding a tyrosine kinase receptor that plays an important role in tumor growth and metastasis. The National Comprehensive Cancer Network (NCCN) guidelines have approved carbatinib/crizotinib for advanced non-small ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Hongge, Zhou, Dexun, Dai, Lin, Zhang, Moqin, Gao, Zhancheng, Mu, Xinlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581303/ https://www.ncbi.nlm.nih.gov/pubmed/34778041 http://dx.doi.org/10.3389/fonc.2021.727662

Ejemplares similares

LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report
por: Yang, Yanlong, et al.
Publicado: (2022)

Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion
por: He, Jing, et al.
Publicado: (2023)

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy
por: Ryu, Woo Kyung, et al.
Publicado: (2022)

Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy
por: Wu, Jinchun, et al.
Publicado: (2021)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
por: Dardare, Julie, et al.
Publicado: (2022)

The crosstalk between anoikis and epithelial-mesenchymal transition and their synergistic roles in predicting prognosis in colon adenocarcinoma
por: Zhou, Jiahui, et al.
Publicado: (2023)

Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
por: Wang, Sha-Sha, et al.
Publicado: (2022)

Advances in the relationship between ferroptosis and epithelial–mesenchymal transition in cancer
por: Mu, Wenrong, et al.
Publicado: (2023)

Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel TPR-ROS1 Fusion
por: Wei, Shuli, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib
por: Xue, Feng, et al.
Publicado: (2022)

Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
por: Wang, Sha-Sha, et al.
Publicado: (2022)

Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition
por: Huang, Shuai, et al.
Publicado: (2022)

A Novel Intergenic Gene Between SLC8A1 and PKDCC-ALK Fusion Responds to ALK TKI WX-0593 in Lung Adenocarcinoma: A Case Report
por: Du, Jia, et al.
Publicado: (2022)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2022)

Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report
por: Qin, Ruo-Yan, et al.
Publicado: (2021)

Case report: complete remission with crizotinib in ROS1 fusion-positive sinonasal mucosal melanoma
por: Cao, Jun, et al.
Publicado: (2022)

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer
por: Jiang, Jingwen, et al.
Publicado: (2022)

Novel PPFIA1-ALK, ALK-C2orf91(intergenic) double-fusion responded well to alectinib in an advanced lung adenocarcinoma patient: a case report
por: Yan, Lingxin, et al.
Publicado: (2023)

ALK gene expression status in pleural effusion predicts tumor responsiveness to crizotinib in Chinese patients with lung adenocarcinoma
por: Wang, Zheng, et al.
Publicado: (2016)

Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model
por: Shi, Jianguang, et al.
Publicado: (2021)

Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib
por: Zhai, Xiaoqian, et al.
Publicado: (2023)

The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
por: Vella, Laura Jayne
Publicado: (2014)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma
por: Pan, Yujin, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)

Role of Glycans in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
por: Li, Xiang, et al.
Publicado: (2016)

Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
por: Lindsey, Stephan, et al.
Publicado: (2014)

Epithelial to mesenchymal transition in tumor cells as consequence of phenotypic instability
por: García de Herreros, Antonio
Publicado: (2014)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

Role of LncRNAs in the Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2021)

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies
por: Qiao, Lili, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer
por: Gelissen, Julia H., et al.
Publicado: (2022)

Editorial: Molecular mechanisms of epithelial-mesenchymal transition in cancer metastasis
por: Amin, Amr, et al.
Publicado: (2022)

Case Report: Response to crizotinib treatment in a patient with advanced non-small cell lung cancer with LDLR-ROS1 fusion
por: Shu, Yun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eci26vr95oahs4i9k96jharm28